Skip to main content

Table 1 Clinical and demographical characteristics of the patients or ulcers

From: Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers

Characteristics

Results (N = 1788 patients)

Age (years): median ± QR (minimum; maximum)

65.0 ± 14.0 (19; 98)

Gender: masculine/feminine (% feminine)

825/963 (53.9%)

Ethnic groups (24 missing)

White

1132 (63.3%)

Black

289 (16.2%)

Mixed

333 (18.6%)

 

Chinese

10 (0.6%)

Diabetes mellitus: type 1/type 2 (% type 2) (47 missing)

379/1362 (76.2%)

Smokers (6 missing)

368 (20.6%)

Arterial hypertension (4 missing)

1085 (60.7%)

Ischemic cardiopathy (9 missing)

411 (23.0%)

Antecedents of foot ulcers

662 (37.0%)

Antecedents of amputations

420 (23.5%)

 

N = 1835 ulcers

Etiology of the ulcer (1 missing)

Ischemic

790 (43.1%)

Non ischemic

1044 (56.9%)

Location-extension of the lesion (118 missing)

Simple

1140 (62.1%)

Complex

354 (19.3%)

 

Calcaneal

223 (12.2%)

Wagner’s classification (83 missing)

  

Grade 1

26 (1.4%)

Grade 2

228 (12.4%)

Grade 3

981 (53.5%)

Grade 4

504 (27.5%)

 

Grade 5

13 (0.7%)